GlobeNewswire by notified

Information regarding trading suspension in connection with U.S. reregistration process and notice of ticker change

Share

Bermuda, March 14, 2023: Reference is made to the press release published by Cool Company Ltd. (“CoolCo” or the “Company”) on February 14, 2023 regarding the Company’s public filing of a registration statement with the U.S. Securities and Exchange Commission to list its common shares on the New York Stock Exchange (“NYSE”) and on March 10, 2023 regarding the conclusion of the regulatory review process for the NYSE Listing and the update on the trading suspension.

In connection with the listing of the Company’s shares on the NYSE and to facilitate the transfer of the Company’s shares between the NYSE and Euronext Growth Oslo, the Company will amend the registration structure for its shares (the “Reregistration Process”). A trading suspension of the Company’s shares will be required in connection with the Reregistration Process (the “Trading Suspension”). Further, the Company will change its ticker code on Euronext Growth Oslo from “COOL” to CLCO” effective from and including March 17, 2023. 

Details on the Trading Suspension in CoolCo’s Shares

Due to the technical settlement requirements of Euronext Securities Oslo (the “VPS”), the central securities depository in Norway where the Company’s shares are registered, the Trading Suspension will be required from and including March 15, 2023 to and including March 16, 2023. Oslo Børs has approved the Company’s request for the Trading Suspension.

During the Trading Suspension, the Company’s shares will be temporarily suspended from trading on Euronext Growth Oslo. From the perspective of an investor holding the Company’s shares in the VPS, the last settlement cycle for shares traded prior to the Trading Suspension will take place on March 16, 2023. Investors trading in the Company’s shares prior to start of the Trading Suspension should not agree to settlement periods that would provide for settlement after March 16, 2023. Any such trades with settlement after March 16, 2023 are expected to be cancelled.

Following completion of the Reregistration Process, the Trading Suspension will end and the Company’s shares will resume trading as normal, which is expected to occur from and including the start of trading on March 17, 2023.

Set out below is the anticipated timeline of the Trading Suspension:

  • March 14, 2023: Last day of trading in the Company’s shares on Euronext Growth Oslo prior to the Trading Suspension. All trades done on March 14, 2023 must be executed with regular settlement T+2 or shorter.
  • March 15, 2023: Trading Suspension on Euronext Growth Oslo.
  • March 16, 2023: Trading Suspension on Euronext Growth Oslo. Reregistration Process expected to be completed.
  • March 17, 2023: Expected end of the Trading Suspension and the Company’s shares will resume normal trading from start of trading on Euronext Growth Oslo.

No action is required by an investor holding shares in the VPS in connection with the Trading Suspension, and investors’ holdings will continue to be registered in the VPS.

Reference is made to the press release published by the Company on February 14, 2023 for further details on the effects of the Reregistration Process on procedures for exercising shareholder rights, etc.

Details on Ticker Change

In connection with the listing of the Company’s shares on the NYSE, the Company’s ticker code on Euronext Growth Oslo will change from “COOL” to “CLCO”. The change will take effect from and including March 17, 2023.

ABOUT COOLCO

CoolCo is a growth-oriented owner, operator and manager of fuel-efficient liquefied natural gas (“LNG”) carriers. Using its integrated, in-house vessel management platform, CoolCo provides charterers and third-party LNG vessel owners with modern and flexible management and transportation solutions, delivering a lesser-emitting form of energy that supports decarbonization efforts, economic growth, energy security, and improvements in quality of life. CoolCo intends to leverage its industry relationships to make further accretive acquisitions of in-service LNGCs, and to selectively pursue newbuild opportunities.

Additional information about CoolCo can be found at www.coolcoltd.com.

For further information, please contact:

ir@coolcoltd.com

Forward-looking Statements

This press release contains forward-looking statements which include statements with respect to the Company’s planned listing on the NYSE, including the expected timing thereof and plans with respect to amending the registration structure for our shares, including a planned suspension of trading and the expected timing thereof, our business and other non-historical statements.  Forward-looking statements are typically identified by words or phrases, such as “about”, “believe,” “expect,” “plan,” “goal,” “target,” “strategy,” and similar expressions or future or conditional verbs such as “may,” “will,” “should,” “would,” and “could.” Forward-looking statements are based on our current estimates or expectations of future events or future results and are subject to risks and uncertainties and actual results could differ materially from those indicated by these statements, including risks described under the section captioned “Risk Factors,” in  CoolCo’s registration statement on Form 20-F filed with the SEC on March 7, 2023, which contains additional information about factors that could affect actual results, including risks relating to our industry, business operations, financing and liquidity, regulation and other risks described in the registration statement.  The forward-looking statements included in this press release are made and based on information available at the time of the release, and the Company assumes no obligation to update any forward-looking statement.

This information is subject to the disclosure requirements in Regulation EU 596/2014 (MAR) article 19 number 3 and section 5-12 of the Norwegian Securities Trading Act.

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Fortuna files Form 40-F, Annual Report30.3.2023 23:15:00 CEST | Press release

VANCOUVER, British Columbia, March 30, 2023 (GLOBE NEWSWIRE) -- Fortuna Silver Mines Inc. (NYSE: FSM) (TSX: FVI) reports that the Company has filed today its fiscal 2022 annual report on Form 40-F with the U.S. Securities and Exchange Commission (“SEC”). The Form 40-F, which includes the Company’s fiscal 2022 annual audited financial statements, management’s discussion and analysis, and annual information form, is available on the Company’s website and on the SEC´s website. Printed copies of the annual financial statements are available free of charge to Fortuna shareholders upon written request. About Fortuna Silver Mines Inc. Fortuna Silver Mines Inc. is a Canadian precious metals mining company with four operating mines in Argentina, Burkina Faso, Mexico and Peru, and a fifth mine under construction in Côte d'Ivoire. Sustainability is integral to all our operations and relationships. We produce gold and silver and generate shared value over the long-term for our stakeholders through

Samlede antal stemmerettigheder og aktiekapital i Pharma Equity Group A/S ("Selskabet")30.3.2023 23:13:48 CEST | pressemeddelelse

Pharma Equity Group A/S Selskabsmeddelelse Årets meddelelse nr.: 24 Dato: 30. marts 2023 Samlede antal stemmerettigheder og aktiekapital i Pharma Equity Group A/S ("Selskabet") I henhold til Lov om kapitalmarkeder (lovbekendtgørelse nr. 41 af 13. januar 2023) § 32 offentliggør Selskabet hermed det samlede antal stemmerettigheder og den samlede aktiekapital i Selskabet. Efter kapitalforhøjelse registreret den 24. marts 2023 vedrørende udstedelse af vederlagsaktier til aktionærerne i Reponex Pharmaceuticals A/S og nye aktier med fortegningsret for Selskabets eksisterende aktionærer i en fortegningsretsemission, hvor Selskabet i alt udstedte 978.584.263 stk. nye aktier à nominelt DKK 1,00 pr. aktie, udgør Selskabets samlede nominelle aktiekapital DKK 1.022.963.883 svarende til 1.022.963.883 antal aktier og 1.022.963.883 stemmer pr. 31. marts 2023 Yderligere information Alle henvendelser vedrørende ovenstående bedes venligst rettet til direktør Peter Ole Jensen på e-mailadressen: peter.ole

Multitude Group Annual Report for 2022 published30.3.2023 22:45:00 CEST | Press release

Multitude Group Annual Report for 2022 published Helsinki, 30 March 2023 – Multitude SE (ISIN: FI4000106299, WKN: A1W9NS) (“Multitude” or the “Group”) is pleased to announce that the Group's Annual Report, Corporate Governance Statement and Remuneration Report for the year ended 31 December 2022 have been published today on the company’s website. The Annual Report consists of annual review and financial review, including Board of Directors‘ report, consolidated financial statements and parent company’s financial statements. The annual review includes the ESG Report 2022 which comprises the non-financial statement. It outlines the Group’s ESG Goals and KPIs focused on people, processes, and the environment, with commencement of reporting on the Group’s carbon emissions. The ESG report 2022 further highlights the Group’s commitment to customer well-being through responsible lending practices and the introduction of a Responsible Lending Index and a commitment to progress on employee well

Zealand Pharma announces completion of a directed issue and private placement of 6,578,948 million new ordinary shares raising gross proceeds of DKK 1.5 billion30.3.2023 22:45:00 CEST | Press release

Company announcement – No. 11 / 2023 Zealand Pharma announces completion of a directed issue and private placement of 6,578,948 million new ordinary shares raising gross proceeds of DKK 1.5 billion NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA, EXCEPT AS PERMITTED BY APPLICABLE LAW. THIS ANNOUNCEMENT IS NOT AN OFFER OF SECURITIES FOR SALE IN THE UNITED STATES AND THE SECURITIES REFERRED TO HEREIN MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES ABSENT REGISTRATION EXCEPT PURSUANT TO AN EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE U.S. SECURITIES ACT; ANY PUBLIC OFFERING OF SUCH SECURITIES TO BE MADE IN THE UNITED STATES WILL BE MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM THE ISSUER, WHICH WOULD CONTAIN DETAILED INFORMATION ABOUT THE COMPANY AND MANAGEMENT, AS WELL AS FINANCIAL STATEMENTS. As announced on 30 March 2023, Zealand Pharma commenced

Multitude SE: Notice to Convene Multitude SE's Annual General Meeting of Shareholders30.3.2023 22:45:00 CEST | Press release

NOTICE TO CONVENE MULTITUDE SE’S ANNUAL GENERAL MEETING OF SHAREHOLDERS Notice is given to the shareholders of Multitude SE (Company) that the Annual General Meeting of the Company is to be held on 27 April 2023 at 10:00 a.m. (EEST / Finnish time) at the offices of Castrén & Snellman Attorneys Ltd, Eteläesplanadi 14, Helsinki, Finland. The reception of persons who have registered for the meeting and the distribution of voting tickets will start at 9:30 a.m. (EEST / Finnish time). Shareholders may also exercise their voting rights by voting in advance. Instructions concerning advance voting are provided in Section 3.4 of this notice. It will not be possible to participate in the meeting or follow the meeting via an online stream or otherwise in real time by the use of telecommunication connections or technical means. The meeting will be held in the English language. 1 MATTERS ON THE AGENDA OF THE GENERAL MEETING OF SHAREHOLDERS At the General Meeting of Shareholders, the following matte